Clorox Director Stephanie Plaines Receives Deferred Stock Units
CLOROX CO /DE/
Subscribe to track CLX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
### Clorox Co ($CLX) Insider Filing
**Reporting Owner:** Stephanie Plaines (Director)
**Filing Date:** October 2, 2026 | **Transaction Date:** September 30, 2026
**Transaction Overview:**
- **Security:** Deferred Stock Units
- **Type:** Acquisition (Award / Fee Election)
- **Shares Added:** 339.4642 units (plus 98.9603 units via dividend reinvestment)
- **Price:** $0.00
- **Post-Transaction Holdings:** 8,555.5518 units
*Note: Units were acquired in lieu of quarterly director fees and through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.*
Comprehensive Analysis
Insider Transaction Overview
On October 2, 2026, Clorox Co ($CLX) director Stephanie Plaines reported transactions in Deferred Stock Units pursuant to a Form 4 filing:
- Quarterly Director Fees Deferral (2026-09-30): Plaines acquired 339.4642 Deferred Stock Units at an effective cost of $0.00 in lieu of receiving cash quarterly director's fees.
- Dividend Reinvestment (2026-08-28): Plaines acquired 98.9603 Deferred Stock Units via dividend reinvestment pursuant to the Independent Directors' Deferred Compensation Plan.
Following these transactions, Plaines directly holds 8,555.5518 Deferred Stock Units. Each unit converts to common stock on a 1-for-1 basis upon retirement or termination of board service.
Trading Significance
The trading significance is assessed as Low. These transactions represent routine non-employee director compensation deferrals and automatic dividend reinvestments rather than discretionary open-market purchases or sales.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.